Cannata, CBackhaus, TBramke, ICaraman, MLombardo, AMoermond, CTA2023-12-182023-12-182023-12-1810.1016/j.envint.2023.108379http://hdl.handle.net/10029/627142enPrioritisation of data-poor pharmaceuticals for empirical testing and environmental risk assessmentArticleEnviron Int 2024;183:108379